Current Opinion in Neurology

Article	Citations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	58
Update on management of cerebral venous thrombosis	54
The recent surge of functional movement disorders: social distress or greater awareness?	54
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	50
Management of neuropsychiatric symptoms in dementia	47
The role of the gut microbiome in Alzheimer's disease pathophysiology	45
Editorial introductions	43
From basic mechanisms to therapeutic perspectives in cluster headache	39
Neurosyphilis in 2025: Erratum	38
Microglia in multiple sclerosis – pathogenesis and imaging	37
Neuro-oncology is moving quickly toward new horizons of diagnosis and treatment	36
Gene therapies for CMT neuropathies: from the bench to the clinic	33
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	31
Hereditary motor neuropathies	31
Central nervous system adverse events of immune checkpoint inhibitors	30
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	29
Neurology education in the era of artificial intelligence	27
Historical development and contemporary use of neuromodulation in human spinal cord injury	24
Editorial: Epilepsy advances in 2023	23
Editorial introductions	23
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	23
Updates in neuro-otology	23
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial	22
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management	22
Connecting tremors – a circuits perspective	22

Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms	22
Threat of resurgence or hope for global eradication of poliovirus?	22
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	22
Multiple sclerosis in China: the current state of diagnosis and management	22
Clinical impact of molecular profiling in rare brain tumors	22
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	21
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment	21
Nerve ultrasound in the diagnosis of inflammatory neuropathies	21
Migraine in women: a review	20
Thymectomy in myasthenia gravis	20
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	20
The FSHD jigsaw: are we placing the tiles in the right position?	20
Levodopa infusion therapies for Parkinson disease	20
Gauging and controlling excitability in cortical disorders	19
Acute stroke care in low and middle-income countries	19
Update on the clinical and therapeutic aspects of myotonic dystrophy type 1	19
Electrical stimulation of the peripheral and central vestibular system	19
Idiopathic intracranial hypertension: expanding our understanding	18
fMRI-based spatio-temporal parcellations of the human brain	18
Red flags in multiple sclerosis	18
MRI for the diagnosis of limb girdle muscular dystrophies	17
Diet and migraine: what is proven?	17
Obesity-related neuropathy: the new epidemic	17
Update on dermatomyositis	17
New developments in diagnostics and treatment of adult-onset focal dystonia	16
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	16
Targeting IDH1/IDH2 mutations in gliomas	16
Editorial: The gap between academic advances and therapy development in motor neuron disease	16
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	16
Optic neuritis: current challenges in diagnosis and management	16
Parkinson's disease – genetic cause	16
Neurosyphilis in 2025	16
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies	16
Novel approaches to treatment of leptomeningeal metastases	15
Recent advances in Alzheimer disease genetics	15
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	15
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	15
Neuroinflammation and immunometabolism in neurodegenerative diseases	15
Sex and gender differences in neurological infections	15
Progress in spinal muscular atrophy research	15
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond	14
Diagnosing viral encephalitis and emerging concepts	14
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	14
New insights in the immune treatment of Guillain–Barré syndrome	14
Recent insights in striated muscle laminopathies	14
Fluid phase biomarkers in multiple sclerosis	14
Visually induced dizziness	14
Current trend in air pollution exposure and stroke	14
Abnormal energy metabolism in ALS: a key player?	13
Monitoring multiple sclerosis: digital and fluid phase biomarkers	13

The state of art on the use of patient reported outcomes in migraine	13
Update on genetics of amyotrophic lateral sclerosis	13
Update on modifiable risk factors for Alzheimer's disease and related dementias	12
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	12
Vestibular migraine. Clinical and diagnostic challenges, and emerging therapeutic approaches	12
Editorial introductions	12
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders	12
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	12
Editorial: Making the invisible visible: updates on vestibular neurology	12
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	12
Imaging cortical lesions in multiple sclerosis	12
Imaging of vestibular function and disorders and its clinical relevance	12
Long COVID and especially headache syndromes	11
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	11
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	11
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury	11
Current gaps in acute reperfusion therapies	11
Editorial: Seizure disorders: 2023 update	11
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	11
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	11
Therapeutic thoroughfares for adults living with Pompe disease	11
Muscle ultrasound in myopathies	11
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy	11
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	11
Peripheral visual field loss and activities of daily living	11
Multiple sclerosis: advances and challenges in diagnosis	11
Progress in treatment of gliomas	11
Deep brain stimulation of the mesencephalic locomotor region or lateral hypothalamus for facilitation of walking after spinal cord injury	10
Editorial: Cerebrovascular disease	10
Interrogating large multiple sclerosis registries and databases: what information can be gained?	10
Nonneurologic causes of binocular diplopia for the neurologist	10
Perception and control of a virtual body in immersive virtual reality for rehabilitation	10
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?	10
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period	10
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success	10
Neuro-infectious disorders – reasons to be cheerful but it is a long and winding road	9
Editorial introductions	9
How to evaluate extent of resection in diffuse gliomas: from standards to new methods	9
Atypical forms of Alzheimer's disease: patients not to forget	9
Editorial: Advances in brain tumors management: new perspectives and challenges	9
Ménière's disease: new guidelines, subtypes, imaging, and more	9
Progression in multiple sclerosis – a long-term problem	9
Editorial introductions	9
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment	9
Acute vertigo: stroke or not?	9
An update on psychogenic nonepileptic seizures	9
Barriers to clinical genetic testing in movement disorders	9
Emerging concepts and therapies for amyotrophic lateral sclerosis	9
Editorial:Framing artificial intelligence to neuromuscular disorders	9
New targets in spontaneous intracerebral hemorrhage	9
Editorial: Advances in stroke management and upcoming challenges	8
The current landscape of epilepsy genetics: where are we, and where are we going?	8
Shifting our attention earlier in the multiple sclerosis disease course	8
Artificial intelligence in neuroimaging of brain tumors: reality or still promise?	8
Headache in infections	7
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	7
Editorial improving movement disorders healthcare across the globe	7
Vestibular and auditory manifestations of migraine	7
Editorial: Current opinions in neurology editorial	7
Editorial introductions	7
Lesion network mapping for symptom localization: recent developments and future directions	7
Editorial introductions	7
PET-based brain molecular connectivity in neurodegenerative disease	7
Deep brain stimulation access in 2025: geographic, gender, racial, and socioeconomic disparities re-examined	7
Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis	6
Guillain-Barré syndrome in an era of global infections and 21st century vaccination	6
New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	6
The role of caffeine in headache disorders	6
Leprous neuropathy	6
Editorial introductions	6
Editorial introductions	6
Congenital myasthenic syndromes: increasingly complex	6
Imaging and neuromodulation in Parkinson's disease	6
The genetics of amyotrophic lateral sclerosis	6
Recent insights into haematology and peripheral nerve disease	6
Recent advances in stroke biomarkers – implications for prognosis and treatment	6
Autoimmune neuromyotonia	6
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies	6
Endogenous clues promoting remyelination in multiple sclerosis	6
Rescue therapies in epilepsy	6

Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications	6
Socioeconomic disparities in epilepsy care	6
Editorial: Update on movement disorders	6
Novel pathophysiological insights in autoimmune myasthenia gravis	6
Brain health in HIV: pathogenesis, classification, and treatment	6
Recent developments in multiple sclerosis neuropathology	5
Vestibular syncope	5
Current drug treatment of myasthenia gravis	5
Neuroimaging endpoints for clinical trials in gliomas: the neuro-oncologist perspective	5
Does imaging of the ischemic penumbra have value in acute ischemic stroke with large vessel occlusion?	5
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease	5
Genetics of ALS – genes and modifier	5
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	5
Spasticity following brain and spinal cord injury: assessment and treatment	5
Novel trial designs in neuro-oncology	5
Ambulatory seizure detection	5
Characterization, etiology, and management of neurocognitive impairment in patients with glioma: an evidentiary update	5
Recent advances in the genetics of Parkinson's disease in underrepresented populations	5
Medical and neurologic management of brain tumor patients	5
Autoimmune nodopathies, an emerging diagnostic category	5
Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond	5
Current concepts in acute vestibular syndrome and video-oculography	5
Neurotoxicity from chimeric antigen receptor T-cells: an update on diagnosis and treatment	5
Current understanding of skeletal muscle repeat expansion disorders	5
Update on myelin imaging in neurological syndromes	5
An update on multiple system atrophy	5
Recent advances in epilepsy surgery	5
Emerging neuroinfectious diseases: public health implications	5
Persistent aura without infarction	5
The evolving spectrum of complex inherited neuropathies	5
Advances in myopathy research: promising developments and challenges	4
Somatic mosaicism in focal epilepsies	4
Imaging of sleep disorders in pre-Parkinsonian syndromes	4
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials	4
Recent advances in our understanding of genetic rhabdomyolysis	4
Assessment and treatment of neurogenic dysphagia in stroke and Parkinson's disease	4
Systemic vasculitis and headache	4
Editorial introductions	4
Promoting exogenous repair in multiple sclerosis: myelin regeneration	4
Immunology of multiple sclerosis: an update	4
Late-onset myopathies	4
Neuropathology and epilepsy surgery	4
Recent advances, challenges and perspectives in cerebrovascular disease	4
Defining the presymptomatic phase of frontotemporal dementia	4
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease	4
Heterogeneity of frequencies of motor neuron disease across ethnicities and geographical areas: focus on Arabic countries in the Mediterranean area	4
Describing and assessing behavioural symptoms in amyotrophic lateral sclerosis with and without frontotemporal dementia: a scoping review	4
Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies	4
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?	4
Enzyme replacement therapies in adults with Pompe disease: from trials to real-world data	4
The current clinical perception of myotonic dystrophy type 2	4